SaiHemanthChavalaMD

Ophthalmology • Dallas, TX

Retinal Disease

Professor, North Texas Eye Research Institute, University of North Texas at Fort Worth

Join to view full profile

Dr. Chavala is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Chavala's full profile

Already have an account?

Office
11615 Forest Central Dr Unit 308
Dallas, TX 75243
Phone+1 214-233-6170

Fax+1 214-241-4947

Education & Training

Duke University HospitalFellowship, Ophthalmology, 2007 - 2009
Cleveland Clinic FoundationResidency, Ophthalmology, 2002 - 2005
New York Downtown HospitalInternship, Internal Medicine, 2001 - 2002
University of Missouri Kansas City School of MedicineClass of 2001

Certifications & Licensure

TX State Medical License 2014 - 2025
NC State Medical License 2007 - 2016
OH State Medical License 2002 - 2015
American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Fellow (FAAO) American Academy of Ophthalmology

Publications & Presentations

PubMed

6 citations
Biodistribution of adeno-associated virus type 2 carrying multi-characteristic opsin in dogs following intravitreal injection.
Kissaou T. Tchedre, Subrata Batabyal, Melissa Galicia, Darryl Narcisse, Sourajit Mitra Mustafi
Journal of Cellular and Molecular Medicine. 2021-08-21
Erratum: Hybrid compound SA-2 is neuroprotective in animal models of retinal ganglion cell death (Investigative Ophthalmology and Visual Science (2019) 60 (3064–3073) ...
Dorota L. Stankowska, Adnan Dibas, Linya Li, Wei Zhang, Vignesh R. Krishnamoorthy
Investigative Ophthalmology & Visual Science. 2019-09-01
Hybrid Compound SA-2 is Neuroprotective in Animal Models of Retinal Ganglion Cell Death.
Dorota L Stankowska, Adnan Dibas, Linya Li, Wei Zhang, Vignesh R Krishnamoorthy
Investigative ophthalmology & visual science. 2019-07-28

Press Mentions

Phase 1/2a Trial of Multi-Characteristic Opsin Gene TherapyOctober 8th, 2021
Paragon Biosciences CEO Jeff Aronin Commends Dr. Sai Chavala’s Recent ARVO AwardJune 10th, 2021
Cones Derived from Human Stem Cells Help Mice See: StudyApril 23rd, 2021
Join now to see all

Grant Support

Regulation Of Adult Ciliary Body Progenitor Cells For Cell Replacement TherapyNational Eye Institute2011–2012

Professional Memberships

American Academy of Ophthalmology - AAO
Fellow